Secondhand Smoke Linked to Worse Infant Eczema

Study examines smoke exposure and eczema severity

Passive tobacco-smoke exposure was associated with more severe nonallergic atopic dermatitis in children aged from birth to 24 months in a study reported in Advances in Dermatology and Allergology.

The analysis included 104 children diagnosed with nonallergic atopic dermatitis. Researchers led by Halil Alkaya of Ümraniye Training and Research Hospital in Istanbul evaluated whether early-life passive smoke exposure was associated with disease severity. Severity was assessed with the Scoring Atopic Dermatitis, or SCORAD, measure.

The findings are observational: they report associations between exposure and severity in the study group. They do not establish that smoke exposure caused an individual child’s eczema to become more severe.

Higher scores among children with smoking parents

Children whose parents smoked had substantially higher SCORAD scores than children whose parents did not smoke. The reported average score was 33.42 for children with smoking parents, compared with 11.64 for those with nonsmoking parents.

The researchers also reported a relationship between the duration of prenatal passive-smoke exposure and SCORAD scores. Scores rose across the categories used in the analysis:

• 19.42 among children with no prenatal exposure;
• 24.73 among those exposed one to two hours per day;
• 28.49 among those exposed two to four hours per day; and
• 38.74 among those exposed more than four hours per day.

Those figures show an exposure pattern within this cohort: longer reported passive exposure during pregnancy corresponded with higher average severity scores. The source also reports significant associations for paternal active smoking and for categories of paternal passive-smoke exposure duration.

Prenatal and household exposure

Both prenatal passive-smoke exposure and postnatal household smoking were associated with significantly higher SCORAD scores in the study. The result places attention on the child’s environment before and after birth, rather than only on a single period of exposure.

One distinction in the findings is that maternal active smoking during pregnancy was not significantly associated with disease severity in this analysis. That result should not be read as a broader finding about tobacco exposure and child health; it is the reported result for disease severity in this specific group of children with nonallergic atopic dermatitis.

The study’s focus was also narrow. It examined children already diagnosed with nonallergic atopic dermatitis, not the likelihood that smoke exposure will cause eczema to develop in the general population. Its principal outcome was the severity of existing disease, measured by SCORAD.

Prevention and family smoking cessation

The authors say the findings highlight the importance of early preventive strategies and family-based smoking-cessation interventions. In practical terms, the study’s result concerns household and family exposure patterns, including paternal smoking and postnatal smoking in the home.

Atopic dermatitis is commonly described as eczema, but the research report specifically addresses the nonallergic form in very young children. Parents and caregivers should avoid treating the reported group averages as a forecast for any individual child. Clinical assessment remains important because severity can vary from child to child and because this study measured associations rather than proving a direct causal pathway.

Even with those limits, the size of the differences reported between the smoking-parent and nonsmoking-parent groups, along with the exposure-duration pattern, makes the study relevant to discussions of household tobacco smoke around infants and toddlers with this condition. The authors’ conclusion is directed toward early prevention and family-level support to stop smoking.

This article is based on reporting by Medical Xpress. Read the original article.